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Abstract:
Amongst  high-risk human papillomaviruses  (HPV),  HPV-16 infection  is  the most 
prevalent causative factor for cervical cancer. Beside other mucosal targets, HPV-16 
was reported to infect the placenta and to replicate in trophoblastic cells. Since these 
cells  share  invasive  properties  of  tumoral  cells,  they  represent  an  ideal  model  to 
investigate several oncogenic processes. In the present work, we analyzed the impacts 
of  HPV-16  E5,  E6  and  E7  oncoproteins  on  the  trophoblastic  model.  Our  results 
showed that E5 impaired the viability of trophoblastic and cervical cell lines but E6 
and  E7, favouring cell growth, neutralised the E5 cytotoxic effect.  In addition,  E5 
decreased the adhesiveness of trophoblastic cells to the tissue culture plastic and to 
endometrial cells similarly as previously described for E6 and E7. E5 and E6 plus E7 
increased also their migration and their invasive properties. Cells expressing HPV-16 
early proteins under the control of the LCR endogenous promoter displayed growth 
advantage  and  were  also  more  motile  and  invasive  compared  to  control  cells. 
Interestingly, the E-cadherin was down regulated in trophoblastic cells expressing E5, 
E6 and E7. NF-κB and AP-1 activities were also enhanced.  In conclusion, HPV-16 
early proteins enhanced trophoblastic growth and intensify the malignant phenotype 
by  impairing  cell  adhesion  leading  to  increased  cellular  motile  and  invasive 
properties. HPV-16 E5 participated, with E6 and E7, in these changes by impairing E-
cadherin expression, a hallmark of malignant progression.
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Introduction
Human  papillomaviruses  (HPVs)  are  a  group  of  small  DNA  viruses  with 
epitheliotropic cutaneomucosal tropism. The genital infections are commonly cleared 
within two years but a subset of HPVs termed “high risk” may persist, and in rare 
cases lead to pre-malignant lesions and to invasive carcinoma. The high risk HPV-16 
is the most common sexually transmitted HPV types. Infection with HPV-16 is the 
cause of 50 to 70% of cervical cancers, the second most frequent cause of death by 
cancer among females worldwide (Reviewed in [1]). The oncogenic effect of HPV16 
is commonly attributed to the E6 and E7 viral proteins that abrogate the cell-cycle 
checkpoints  by inactivating tumor suppressors, such as p53 and pRb, respectively, 
and targeting a plethora of other key host cellular proteins involved in apoptosis and 
malignant cellular transformation [2].
Briefly, E6 induces p53 degradation through its association with the cellular protein 
E6-AP via the ubiquitin proteolytic pathway [3]. Several  in vitro and in vivo studies 
reported  other  E6/E6AP  targets.  Among  those,  PDZ-motif-containing  proteins 
inducing  cell  polarity  loss  [4-7],  Bak,  FADD  and  procaspase  8  interfering  with 
apoptosis [8,9], and NFX1 and hTERT contributing to immortalization [10].
E7  induces  the  degradation  of  pRB  and  its  “pocket”  family  members  via  the 
proteasome  pathway  thereby  releasing  the  transcription  factor  E2F  that  controls 
numerous cellular processes [11]. One cyclin-dependent kinase inhibitor, p16, which 
prevents the phosphorylation of pRb family members, is overexpressed when pRb is 
inactivated  by E7 [12].  E6 and E7 can subvert  the immune system by impairing, 
among  others,  the  expression  of  adhesion  molecules  [13-15]. Deregulation  of 
3
adhesion molecules  is not only a strategy for immune evasion but also a prelude to 
early carcinogenesis and metastatic processes [16]. E6 and E7 have been reported to 
cooperate  with  ErbB-2  in  head  and  neck  carcinogenesis  by  downregulating  E-
cadherin expression [17]. Extracellular  matrix degradation by metalloproteinases is 
dramatically  increased  in  invasive  carcinoma  expressing  E6  and  E7  [18].   All 
together, these data suggest that E6 and E7 oncoproteins are the main determining 
factors of the malignant phenotype in HPV-induced cancers. 
Recent findings have implicated the HPV-16 E5 protein as an important mediator to 
oncogenic transformation. The epidermal growth factor receptor (EGFR) is a potential 
target of E5. The association of E5 with the 16 kDa proton-ATPase subunit could 
alter the endosomal acidification and lead to a subsequent increase of phosphorylated 
EGFR at the cell surface [19,20]. E5 enhances the immortalization potential of E6 and 
E7, and stimulates the proliferation in cooperation with E7 [21,22]. Transgenic mice 
studies showed that E5 alters the growth and differentiation of stratified epithelia and 
induces  epithelial  tumor  [23].  E5  confers  to  cells  the  property  to  grow  in  an 
anchorage-independent manner [24]. Significant morphological changes of the cells 
and  reorganization  of  the  actin  cytoskeleton  were  attributed  to  the  transforming 
potential of E5: inducing koilocyte formation in cooperation with E6 [25], changing 
the lipid composition of the membranes [26,27], inhibiting gap junctional intercellular 
communication [28,29] and increasing cell motility [30].
Surprisingly, recent studies reported that HPV could infect the human placenta and 
that various HPV types could complete their entire life cycle in a trophoblastic cell 
line  [31,32].  The  trophoblast  is  known to  share similar  properties  with malignant 
tumoral cells including invasive and migratory capacities [33]. BeWo cells, known as 
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“trophoblastic-like  cells”,  share many morphologic, metabolic, and functional 
characteristics with trophoblast cells of the normal first trimester placenta [34]. In the 
present work, we used the BeWo cells as a model to study the effects of HPV-16 E5, 
E6 and E7 oncoproteins on trophoblastic growth, adhesion, migration and invasion 




The HPV-16 Early ORF constructs used in this study were engineered to express the 
Flag  tag  (LMDYKDDDDKAAA)  at  their  N  terminus  to  facilitate  immunological 
detection. The pEF6-Flag expression vector was kindly provided by Dr M. Kalai (IPH, 
Belgium). The HPV-16 cloned DNA plasmid template was a kind gift from Pr. E-M. 
De Villiers (DKFZ, Germany). HPV-16E5 coding sequences were amplified by PCR 
using  primers  5’-AAGGCGGCCGCTATGACAAATCTTGATACTGC-3’  and  5’-
ATGCTCTAGACATTATGTAATTAAAAAGCG-3’. The two ORF in tandem HPV-
16E6/E7  was  amplified  using  5’-
AGCGCGGCCGCTATGCACCAAAAGAGAACTGC-3’  and  5’ 
ATGCTCTAGAGATTATGGTTTCTGAGAACAG-3’. PCR products were first sub-
cloned  into  the  TOPO-TA  vector  (Invitrogen),  and  then  inserted  into  NotI/XbaI 
restriction site of pEF6-Flag vector.  All plasmid constructions were verified by DNA 
sequencing. pHPV-16-Early and pLCR-GFP were kindly provided by C. Weyn (ULB, 
Belgium).  pEF6-LacZ (Invitrogen) was used as a negative control. peGFP-NLS was 
provided by Dr. X. Saelens (VIB, Belgium) and pGL4-Luc-Renilla plasmid was a kind 
gift  of  Pr. C.  Van Lint  (ULB, Belgium).  pAP-1-Luc and pNF-κB-Luc were kindly 
provided by Dr. Yves Jacob (Pasteur Institute, France).
- Cell culture and transfections
BeWo and JEG-3 choriocarcinoma cell lines were kindly offered by Pr. A. Pötgens 
(Aachen,  Germany)  and  Pr.  R.  Pijnenborg  (KUL,  Belgium),  respectively.  C33a 
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cervical cell lines were purchased from ATCC (American Type Culture Collection). 
HEC-1A and RL-95 endometrial cell lines were a kind gift from Dr. A. Coosmans 
(KUL,  Belgium).  Cells  were  cultured  in  Dulbecco’s  modiﬁed  Eagle’s  medium 
supplemented with 10 % fetal calf serum, 1 mM L-glutamine, 100 U/ml penicillin, 
and 100 mg/ml streptomycin. For transient transfection experiments, BeWo and JEG-
3  cells  were  transfected  in  6  well  plates  (6  X  105 cells/well)  using  3  µg  DNA 
according  to  the  manufacturer’s  protocol  (JET-PEI,  PolyPlus;  ExGen  500, 
Fermentas). C33a cells were transfected using 3 µg DNA by the phosphate calcium 
method [35]. The transfection efficiency was assessed by transfecting separately or 
co-transfecting 30 ng of peGFP-NLS and was typically 40-60% for BeWo cells. For 
stable transfections, cells were transferred (2.5 X 105 cell/ml) 24 h post-transfection 
into  60  mm  Ø  dish,  and  incubated  for  14  days  with  blasticidin  6.25  µg/ml 
(Invitrogen).  Due to the lack of sequence coding for the blasticidin resistance in the 
pHPV-16Early and pLCR-GFP plasmids, both constructs (2.7 µg) were cotransfected 
in stable transfections with pEF6-LacZ (300 ng). 
- RNA extraction and quantitative real time RT-PCR
Transiently  transfected  cells  were  washed  with  CellScrubTM buffer  (Genlantis)  in 
order to remove the extracellular plasmids. Total cellular RNA was extracted using 
the  Nucleospin  RNA  II  Total  RNA  extraction  kit  including  DNase-I  digestion 
(Macherey-Nagel).  An additional  stringent  DNase-I  reaction  was  performed  using 
TurboDNaseI (Ambion-Applied Biosystems). First-strand cDNAs were generated by 
reverse transcription from 1 μg of total RNA in a total volume of 20 μl using the 
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RevertAid H Minus First strand cDNA synthesis kit containing random hexamers and 
H minus M-MuLV Reverse transcriptase (Fermentas). Quantitative expression of the 
HPV-16E5,  HPV-16E6,  HPV-16E7  and  beta-galactosidase  (LacZ)  genes  was 
analyzed  by  real-time  PCR  using  the  iCycler  iQ  system  and  the  iQ  Sybr  Green 
Supermix (Bio-Rad). cDNAs (100 ng) were amplified in 25 µl total  volume PCR 
reaction with specific primers under the following cycle conditions: 95˚C for 3 min, 
followed by 45 cycles of 95˚C for 30 sec and 59˚C for 30 sec. Gene expression was 
normalized using values obtained for the housekeeping GAPDH gene. The primers 
used  for  the  amplification:  GAPDH,  5’  GAAGGTGAAGGTCGGAGTC  and  5’ 
GAAGATGGTGATGGGATTTC  [36];  16-E5,  5’ 
CGTCCGCTGCTTTTGTCTGTGTCTACATAC  and  5’ 
CACCTAAACGCAGAGGCTGCTGTTATCCAC;  16-E6,  5’ 
GGGAATCCATATGCTGTATGTG and  5’  GCTGTTCTAATGTTGTTCC;  16-E7, 
5’  CAGCTCAGAGGAGGAGGATG and  5’ 
CGCACAACCGAAGCGTAGAGTCACAC;  Beta  galactosidase  (LacZ);  5’ 
GCAGCAGTGATGATCCAGAACT  and  5’ 
CGTAGGTCACAGATGAGCCAATAA. A standard curve was generated for each 
gene. A dissociation curve was performed after each experiment to confirm that a 
single product was amplified. The quantification of transfected transcripts (E5, E6, E7 




Various protein extraction protocols were optimized in order to detect and retrieve the 
viral proteins from distinct sites inside the cells.  The wild type HPV-16 N terminal 
flagged E5 protein was detected by western blotting in transiently transfected BeWo 
cells  using  the  Triton  X114  protocol  recommended  for  hydrophobic  membrane 
associated proteins [37]. Forty-eight hours after transfection, cells were washed twice 
in ice cold PBS then lysed during 1 hour at 4˚C in 500 µl ice-cold Triton X-114 lysis 
buffer (Triton X-114 1%, Tris HCl 10 mM pH 7.4, NaCl 150 mM, EDTA 1 mM, 
protease inhibitors from Roche Applied Science). After centrifugation, supernatants 
were incubated 3 min at 37˚C and centrifuged 1 min at 14000 g for phase separation. 
The lower detergent phase was re-extracted by adding 10 volumes of the Triton X114 
lysis buffer and analyzed. HPV-16 E6 was extracted using the Triton X-100 protocol 
[38]. Briefly,  cells were washed twice in ice cold PBS, then  extracted with a lysis 
buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 2 mM MgCl2, 1% Triton 
X-100,  1  and  protease  inhibitors  (Roche).  After  incubation  on  ice,  lysates  were 
centrifuged at 14,000  g  for 10 min at 4°C. All fractions were stored at -80˚C  and 
quantified using Bradford reagent. Protein extracts (70 µg total protein/lane) or total 
lysates were subjected to 12.5 % or 10 % SDS-PAGE and transferred to nitrocellulose 
membranes. Blocking, antibody incubation steps, and washing of the membrane were 
performed in PBS supplemented with 3 % skimmed milk and 0.05 % Tween 20. Blots 
were incubated with the anti-Flag HRP-conjugated antibody (Sigma) or with mouse 
anti-E-Cadherin  antibody  (BD  Transduction  Laboratories).  Membranes  incubated 
with  primary  antibodies  were  consequently  incubated  with  HRP-conjugated  anti-
mouse secondary antibodies (Amersham Pharmacia Biotech). Blots were incubated 
with  mouse  anti-β-Actin  antibody  to  control  equal  loading  (MP-Biomedicals). 
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Immunoreactive  proteins  were  visualized  using  chemiluminescence,  captured  on 
hypersensitive film (Amersham Pharmacia Biotech). 
- Immunofluorescence confocal microscopy
Forty-eight hours after transfection, BeWo and JEG-3 cells were fixed for 5 min with 
Immunohistofix  (Bio-Rad)  at  room  temperature  followed  by  6  min  with  100% 
methanol at -20°C. After two washes with PBS, the samples were saturated for 1 h 
with PBS containing 0.5% gelatin and 0.25% bovine serum albumin and stained for 1 
h with a 1/10 dilution of an anti-Flag mouse monoclonal immunoglobulin G (IgG) (C-
M2, Sigma). The samples were then washed three times with PBS containing 0.2% 
gelatin and incubated for 1 h with a 1/200 dilution of the secondary antibody: Alexa-
488-coupled goat anti-mouse IgG (Molecular Probes). The samples were then washed 
three times in PBS with 0.2% gelatin and mounted for analysis on a Zeiss LSM510 
laser scanning confocal microscope.
- Cell adhesion assay
BeWo cells (6 X 105) were transiently co-transfected with 30 ng pGL4-Luc-Renilla 
plasmid  and  2.77  μg  pEF6-Flag-HPV-16E5  or  2.77  μg  pEF6-LacZ  as  described 
above.  Forty-eight  hours post transfection,  cells were detached,  resuspended in the 
medium, and counted.  Bewo cells  (8 X 105)  from each transfection were lysed in 
order to assess input luciferase activity. The same number of cells was put in culture 
with or without RL-95 and HEC-1A endometrial  cell lines already attached to the 
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support up to 95% confluence. After 2 h incubation, the attached cells were washed 
and  processed  using  the  Luciferase  Assay  Kit  (Promega).  The  percentage  of 
adhesiveness  was  calculated  by  normalizing  luciferase  activity  founded  in  the 
attached cells to the input of luciferase activity.- Cytotoxicity and viability assays
The LDH release was measured using the Cytotoxicity Detection Kit (Roche) in cells 
supernatants. Thirty hours after transient transfection or 24 h after media refreshments 
of stably transfected cell clones, crystal violet staining was used to assess the cellular 
confluence  after  stable  transfections.  Cells  were fixed with ice-cold methanol  and 
stained for 15 min with crystal violet solution (0.1% in MQ water). After 3 washes, 
dishes were dried at room temperature. Cell staining was eluted in 1 ml of acetic acid 
10% and measured at 540 nm. In stable transfection, LDH values were normalized to 
the crystal  coloration so that the cytotoxicity level could not be biased by the cell 
amount. 
- Luciferase assay
One hundred ng pAP-1-Luc or 50 ng pNF-κB-Luc luciferase reporter plasmids were 
co-transfected  with,  respectively,  700 ng of  pHPV-16 E5 or  750 ng  of  pHPV-16 
E6/E7 and 30 ng pGL4-Luc-Renilla, into BeWo cells (plated in 24 wells plates at 7 X 
104 cells/well  on  the  day  before).  Forty-eight  hours  after  transfection,  cells  were 
harvested and luciferase assays were performed according to the protocol of the Dual 
Luciferase  Assay system (Promega).  Firefly Luciferase  activity  was normalized  to 
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Renilla Luciferase activity to correct for transcription efficiency in each reaction.
- Cell migration and invasion assays
In both migration and invasion assays, 100 µl of BeWo cells (106 cells/ml) in DMEM 
supplemented with 0.1 % BSA were seeded in the upper compartment of the Boyden 
chamber. The same cell number was seeded in 24 wells plate without inserts as an 
input normalization control. The lower compartment was filled with 600 µl of DMEM 
1% BSA supplemented with 10% FCS. The 2 compartments  were separated by a 
porous ﬁlter (8 µm pore). For invasion assay, the filter was coated using 25 µg of 
Matrigel (BD). The chambers were incubated for 24 h at 37°C, then fixed in ice-cold 
methanol and stained with crystal violet (0.1 %). The cells on the upper surface of the 
ﬁlter were scrapped with a cotton swab. Migration and invasion were quantiﬁed by 
elution of the crystal violet in the lower surface of the ﬁlter and in the control wells by 
adding  50  µl  of  acetic  acid  10  %  and  measuring  absorbance  at  540  nm.  The 
percentage of migration or invasion was calculated by normalizing absorbance from 
the lower surface of the filter to the absorbance from the control wells without filter.
- Statistics
Results were obtained from at least 3 independent experiments with using different 
batches  of  DNA.  Data  are  presented  as  means  ±  SD  of  triplicates  from  a 
representative  experiment.  Triplicates  from all  experiments  were  averaged  before 
statistical analysis. Student’s two tailed t-test was used for statistical analysis and a P 
value < 0.05 was considered as statistically significant.
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Results
HPV-16 early proteins expression in trophoblastic cells
To analyze the impact of HPV-16 E5, E6 and E7 early proteins on the physiology of 
trophoblastic  cells,  we first  generated plasmids  for the expression of N-terminally 
flagged E5 or simultaneous expression of both N-terminally flagged E6 and unflagged 
E7  in  tandem under  the  control  of  the  ubiquitous  human  elongation  factor  alpha 
promoter  (hEF-1α). The expression of LacZ,  HPV-16 E5, E6 and E7 genes were 
confirmed in transiently transfected BeWo cells by quantitative real  time RT-PCR 
(Figure  1A).  Figure  1B,  shows that  Flag-E5 protein  formed  monomers  (11  kDa), 
dimers and multimers. In confocal microscopy analysis, HPV-16 E5 was observed in 
internal  membrane  compartments  of  trophoblastic  cells  (Figure 1C),  as previously 
reported in other cell types [24,39]
HPV-16 E6 was retrieved from transiently transfected BeWo cells using the Triton X-
100  lysis  protocol,  as  previously  described  [38]  and  detected  by  immunoblotting 
(Figure 1B). The 18 kDa band corresponds to the predicted size of HPV-16 E6 [40]. 
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The expression of mRNA able to express the unflagged E7 oncogene from the tandem 
pHPV-16E6/E7  construction  was  confirmed  by  quantitative  real  time  RT-PCR 
(Figure 1A). These results showed that HPV-16 E5, E6 are expressed in transfected 
trophoblastic cells (Figure 1A); moreover the presence of E7 mRNA suggested that 
the E7 protein could also potentially be expressed in those cells.
The HPV-16 E6 and E7 bypass the HPV-16 E5 cytotoxic effect, maintain and 
promote viability of trophoblastic and cervical cells
We investigated the effect of the expression of HPV-16 early proteins on the viability 
of the choriocarcinoma BeWo cell line and of the HPV negative cervical carcinoma 
C33a cell line. Cells were stably transfected either with the control plasmid pEF6-
LacZ, with pHPV-16E5, with pHPV-16E6/E7 or with a combination of both pHPV-
16E5 and pHPV-16E6/E7 plasmids. As shown in Figure 2A, HPV-16 E5 induced two 
times more LDH than LacZ control in both BeWo and C33a cells. HPV-16 E6 and 
E7, on the other hand, despite their lower expression (Figure 1A), not only promoted 
viability  but  could also counteract  E5 cytotoxic  effect.  The  crystal  violet  staining 
showed that the number and the size of E5 colonies were smaller than LacZ, E6/E7 or 
E5/E6/E7 colonies in both cell types. Moreover, we noticed that expression of the E5 
mRNA transcripts were not anymore detectable after 5 passages in stable transfection 
(data not shown), on the opposite to the expression of the other transcripts (E6, E7, 
lacZ). The impact of E5, E6 and E7 expression was also studied under endogenous 
viral  regulation  by  stably  transfecting  the  pHPV-16Early  plasmid  in  which  the 
expression of the entire HPV-16 early region is under the control of the viral LCR 
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(Long Control Region).  The expression of all HPV-16 transcripts was confirmed by 
quantitative real time RT-PCR (Weyn et  al. in preparation).  BeWo and C33a cells 
transfected with pHPV-16Early were compared to cells transfected by pLCR-GFP, a 
control plasmid in which the expression of the Green Fluorescent Protein gene (GFP), 
is also under the control of the LCR. As shown in Figure 2B, pHPV-16Early stably 
transfected cells exhibited no cytotoxicity,  with greater colonies number than GFP 
controls (Figure 2B). These results confirmed that physiologically regulated HPV-16 
Early proteins promote the growth of both trophoblastic and cervical cells.
The  AP-1  and  NF-κB  pathways  are  stimulated  by  HPV-16  E5  and  E6/E7 
oncoproteins
According to the viability/cytotoxicity results,  we analyzed  whether the activity of 
AP-1 and NF-κB transcription factors was modified in trophoblastic cells expressing 
either HPV-16 E5 or E6/E7. Compared to LacZ expressing cells, AP-1 activity was 
18 and 60 times higher in cells co-transfected with pHPV-16 E5 or pHPV-16 E6/E7, 
respectively (Figure 3A). On the other hand, cotransfection with pHPV-16E5 induced 
a 4 fold increased in NF-kB acticvation while a 3 fold induction was obtained when 
cotransfecting  pHPV-16  E6/E7  (Figure  3B).  Thus,  HPV-16  E5  or  E6/E7  might 
influence cellular growth via differential activation of AP-1 and NF-κB.
HPV-16 E5 affects the adhesion of trophoblastic cells 
You et  al.  [41] reported that HPV-16 E6/E7 enhanced the malignant phenotype of 
trophoblastic cells and reduced their adhesion to endometrial cells.  Little is known 
concerning HPV-16 E5 involvement in malignant phenotype and its ability to alter 
adhesion capacities. In the present work, we analyzed the effect of HPV-16 E5 on the 
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adhesiveness of BeWo trophoblastic-like cells to the tissue culture plastic and to the 
RL-95  and  HEC-1A  endometrial-like  cells,  a  model  mimicking  trophoblast  cells 
attachment to the endometrial bed. As shown in Figure 4, BeWo cells transfected with 
pHPV-16E5 were less prone to attach to the plastic substrate or to the RL-95 and 
HEC-1A endometrial-like cells, compared to LacZ control. These results suggest that 
HPV-16 E5 reduces adhesiveness of trophoblastic cells to the tissue culture plastic 
and to endometrial cells. HPV-16 E5, like E6 and E7, affects trophoblast adhesion.
HPV-16  E5  and  E6/E7  increase  chemotaxic  and  invasive  properties  of 
trophoblastic cells
In regards to the impact of the HPV-16 E5 on BeWo cells adhesion, we analyzed the 
effect of HPV-16 E5 or E6/E7 expression on BeWo cells motility and invasiveness. 
Compared  to  the  pEF6-LacZ  transfected  control,  pHPV-16E5  transfected  cells 
migrated and invaded slightly more efficiently, while E6/E7 transfected cells migrated 
and invaded even up to two times more easily, (Figure 5A and 5B). Similar results 
were observed with stably transfected BeWo cells (data not shown). Thus, E5, like 
E6/E7 is able to increase the trophoblast malignant phenotype by triggering cellular 
migration and invasion.
When HPV-16 early  proteins  were  expressed  under  the  control  of  the  viral  LCR 
(pHPV-16Early),  cell  migration  and  invasion  were  also  significantly  enhanced 
compared to control cells (Figure 5C and 5D). The number of cells colonies obtained 
by  transfecting  pHPV-16Early  or  pLCR-GFP was  lower  as  the  plasmid  allowing 
blasticidin resistance was cotransfected in a ratio 1 for 10. The expression of HPV-16 
E5,  E6,  E7  under  the  control  of  the  endogenous  original  promoter  (LCR)  or  an 
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ubiquitous promoter (EF-1α) increases motile and invasive properties of trophoblastic 
cells. 
The  trophoblastic  cells  expressing  HPV-16  E5,  E6/E7  and  E5/E6/E7  have 
defective expression of E-cadherin
Several reports showed that the cell-cell adhesion molecule E-cadherin expression is 
altered  during  HPV  carcinogenesis.  Therefore,  the  expression  of  the  E-cadherin 
protein was analyzed by western blotting in total lysates of BeWo cells transiently or 
stably transfected with pEF6-LacZ, pHPV-16 E5, pHPV-16 E6/E7 or co-transfected 
with  pHPV-16  E5  and  pHPV-16  E6/E7  plasmids.  Interestingly,  the  E-cadherin 
expression was decreased not only in BeWo cells expressing HPV-16 E6/E7 but also 
in BeWo cells expressing HPV-16 E5 (tested alone or in the concomitant presence of 
HPV-16 E6 and E7; Figure 6A and 6B). These data suggest that the HPV-16 E5, E6 
and E7 downregulate E-cadherin protein expression in trophoblastic cells.
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Discussion
The  involvement  of  E5,  E6  and  E7 oncoproteins  in  each  stage  of  the  multi-step 
carcinogenesis remains poorly understood and the list of new HPV tissue tropism is 
still  lengthening  (Reviewed  in  [1]).  Recently,  our  group and others  revealed  that 
multiple types of HPV could infect and replicate in human trophoblastic cells [31,32]. 
In the present study, we explored the impacts of HPV-16 E5 and E6/E7 on human 
trophoblastic  cell  lines.  The  trophoblast  represents  a  suitable  model  to  study 
tumorigenesis, since it behaves in a way similar to malignant tumoral cells but obeys 
to rigorous spatial-temporal regulation of growth, migration and invasion during the 
different stages of pregnancy. BeWo cells, baptized “trophoblastic-like cells”  share 
many morphologic, metabolic, and functional characteristics with  primary  human 
trophoblasts of the normal first trimester placenta [34,42]. The aim of this study was 
to evaluate the effects of HPV-16 E5, E6 and E7 oncoproteins on human trophoblasts 
and to identify new molecular targets.
We showed that HPV-16 E5 and E6/E7 genes products can be expressed in BeWo 
transfected cells. The flagged HPV-16 E6 protein was shown to be properly expressed 
from the E6/E7 ORF and the expression of the non-flagged E7 was confirmed by 
quantitative real time RT-PCR. It is known that detection of the small hydrophobic E5 
protein is not easy since a considerable proportion of codons within the HPV 16 E5 
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ORF  are  inefficiently  translated  in  human  cells  [43].  Many  groups  used  SV40 
transformed  cell  lines,  optimized  E5  codons  or  the  tet-off  systems  for  E5 
overexpression [19,43,44]. As observed on Western blot, in an multimerized profile 
the  wild  type  flagged  HPV-16  E5  protein  was  expressed  in  BeWo  cells.  The 
persistence of multimers under reducing conditions could be attributed to the huge 
amount of the hydrophobic E5 protein concentrated in the detergent phase during the 
extraction procedure, favouring protein aggregation [45]. Meanwhile, the localization 
of this protein was observed in internal cell membranes, as previously reported [45]. 
We observed that expression of HPV-16 E5 induced a cytotoxic effect on transfected 
cells. On the contrary, the expression of HPV-16 E6/E7 did not cause any cytotoxicity 
and could abrogate the E5 induced cytotoxicity, even though coexpression of E6 and 
E7 was at least 4 times lower than the expression of E5, according to the quantitative 
real  time RT-PCR data.  Similar  results were observed after  stable transfections or 
transient  transfections,  on two choriocarcinoma cell  lines and on one cervical  cell 
line. These observations suggest that an extended HPV-16 E5 expression alters cell 
viability. 
Although HPV-16 E5 was reported to induce proliferation [46], an extended HPV-16 
E5 expression was reported to be lethal in various cell lines [44,47]. Kabsch et al. 
observed  that  HPV-16  E5  protein  sensitizes  human  keratinocytes  and  mouse 
fibroblasts to apoptosis induced by osmotic stress [48]. By contrast, the same group 
showed  that  E5  expressing  cells  were  less  sensitive  to  Fas  and  TRAIL  induced 
apoptosis [9]. Bravo et al. also discussed a putative correlation between the E5 altered 
lipid composition in keratinocytes membranes and apoptosis [26]. Kivi et al. observed 
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that  microarray  analysis  could  only  be  performed  within  the  first  24  hours  since 
prolonged expression would be lethal to HaCat cells [30]. Codon optimized HPV-16 
E5 expression also reduced  in vitro life span of keratinocytes [24,43]. Furthermore, 
several studies reported that E5 expression is usually transient during HPV productive 
cycle, weak, restricted to undifferentiated cells and that the E5 ORF is often deleted 
when HPV DNA is integrated [49,50]. HPV-16 E6/E7 proteins are known to be the 
major  oncoproteins  and  the  most  relevant  to  malignant  progression  of  HPV-
transformed cells. In the present work, we demonstrated that HPV-16 E6/E7 were not 
only able to maintain and enhance cell growth for long-term expression in both stably 
transfected trophoblastic and cervical cell lines but also to reduce E5 cytotoxicity. The 
positive  effect  of  HPV-16 E6/E7 on trophoblastic  cell  growth confirmed previous 
reports [41] but is in discrepancy with the study by Gomez et al.  [41]. This latter 
group transfected  a  SV40 T antigen  immortalized  trophoblastic  cell  line  with  the 
complete  HPV-16  genome.  Surprisingly,  on  the  opposite  to  many  studies  and 
unexpected for a non-lytic virus, they observed a strong reduction of cell viability in 
the  selected  transfected  cells  and  a  reduced  invasive  phenotype.  Although  they 
detected HPV DNA sequences and L1 protein expression only 7 and 15 days after 
transfection, respectively, they did not study early proteins expression which makes 
interpretation uneasy. 
It  is  difficult  to  assess  which  molecular  signals  could  be  involved  in  the  growth 
advantage induced by HPV-16 early proteins, especially in trophoblastic cells because 
those cells are able to produce virtually all cytokines [51]. As we detected a higher 
transcriptional activity of the AP-1 family transcriptional factors when co-transfecting 
pHPV-16E5, or even more when co-transfecting pHPV-16 E6/E7, it is possible that 
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AP-1  activation  could  play  a  role  in  association  with  other  signalling  pathways. 
Meanwhile,  the  transcriptional  activity  of  NF-κB was significantly  higher  in  cells 
expressing HPV-16 E5 than those  expressing E6/E7,  suggesting  that  AP-1/NF-κB 
balance could be important to promote viability.
Previous reports showed that HPV-16 E6/E7 decreases the trophoblast attachment to 
endometrial cells and might alter trophoblast implantation [41]. In the present report, 
we showed that HPV-16 E5 affects trophoblast adhesion to tissue culture substrate 
and  to  endometrial  cells.  Data  reporting  the  impact  of  E5  on  cell  adhesion  are 
relatively scarce. E5 was reported to alter adhesion signaling [30] and to impair gap 
junction-mediated  cell-cell  communication  by  dephosphorylating  [28]  or 
downregulating connexin 43 [29]. It is well known that the major oncoproteins E6/E7 
affect  adhesiveness  of  several  cell  types  and  enhance  their  malignant  phenotype 
(Reviewed  in  [52]).  The  defect  in  adhesiveness  of  trophoblastic  cells  expressing 
HPV-16 E5 suggests that E5, like E6/E7 might contribute to malignancy and lead to 
potential  abnormal  implantation  of  the  early  embryo  because  of  trophoblasts 
inappropriate spreading. 
Subsequently, according to the lower attachment of E5 or E6/E7 transfected cells to 
various  supports,  we  observed  that  HPV-16  E5  and  in  a  larger  measure  E6/E7 
enhance the trophoblast motility and invasiveness through the extracellular  matrix. 
The expression of either HPV-16 E6 or E7, separately, gave similar results as E6/E7 
expressed in tandem (data not shown). 
E-cadherin impairment  represents  the  hallmark  of  malignancy  and  is  strongly 
associated to a poor prognostic for many tumors [54]. It is not only affecting cell-cell 
21
adhesion,  but  also  cytoskeleton  rearrangement,  cell  adhesion  to  the  extracellular 
matrix and subsequently migration and invasion [15]. E-cadherin is a Ca2+-dependant 
cell-cell  adhesion molecule connecting cells  by direct  E-cadherin contact with one 
another.  The  cytoplasmic  interactions  of  this  transmembrane  molecule  with  the 
cytoskeleton  is  believed  to  be  essential  in  conferring  appropriate  mechanical 
properties to cell-cell adhesion [53].  In the present work, we noticed a significant E-
cadherin protein down regulation in trophoblastic cells expressing HPV-16 E6 or E7, 
separately (data not shown) or in tandem, but also in cells expressing HPV-16 E5 
alone or in presence of HPV-16 E6/E7. Our results are in agreement with previous 
publications, reporting that E6 [15] and E7 [14] could reduce E-cadherin expression. 
It is tempting to suggest that the reduction of adhesion of the BeWo cells expressing 
HPV-16 E5 on  endometrial  cells  could  be,  at  least  partly,  due  to  the  E-cadherin 
downregulation. However, the reduction of adhesion of these cells to the plastic flask 
might involve other mechanisms. 
The transition from epithelial and adhesive cells to mesenchymal and motile cells is 
an important  step during development and tumor progression.  A key event in this 
process is the functional loss of E-cadherin. The NF-κB signalling pathway has also 
been reported to be a critical mediator of this transition. A direct link between the loss 
of the E-cadherin expression and the activation of  NF-κB  activity was reported by 
different groups [55,56]. The induction of snail transcription factor, an inhibitor of the 
E-cadherin gene transcription, could be one of the signalling mediators between these 
two observations [57,58].
It is worth noting that lack of cell adhesion to matrix has in most non-transformed 
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cells an adverse effect on cell survival, inducing a specific type of apoptosis, known 
as anoikis. Disruption of E-cadherin is mainly associated with this process. However, 
activation of AP-1 and NF-κB transcriptional activities,  have been involved in the 
acquisition of anoikis resistance during the epithelial mesenchymal transition process 
[59]. We speculate that partly because of a differential NF-κB versus AP-1 activation 
balance,  E5 could be less favourable to cell survival compared to E6 and E7. Our 
results and a recent publication suggest [60] that the activation of both NF-κB and 
AP-1 by HPV-16 E5 might contribute to carcinogenesis.
In conclusion, our results showed that HPV-16 oncoproteins alter the main human 
trophoblast  functions  by  affecting  its  growth  and  adhesion  and  by  increasing  its 
migratory and invasive properties. The downregulation of E-cadherin expression in 
trophoblastic cells by the HPV-16 E5, E6 and E7 early proteins could at least partially 
explain their reduced adhesiveness and subsequent enhanced migratory abilities. 
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Legends to figures:
Fig.  1.  Expression  of  Flag-  HPV-16  E5,  E6  and  E7  gene  products  in 
trophoblastic cells. (A) Real time RT-PCR detection of the transcripts LacZ, E5, E6 
and E7 in transiently transfected BeWo cells with the negative control pEF6-LacZ (3 
µg), pHPV-16 E5 (3 µg), pHPV-16 E6/E7 (3 µg) or a combination of pHPV-16 E5 
(2.7 µg) and pEF6-HPV-16 E6/E7 (0.3 µg). (B) Immunoblot of Flag-HPV-16 E5 and 
E6 proteins expression in transiently transfected BeWo cells with pHPV-16 E5 and 
pHPV-16 E6/E7. (C) Immunofluorescence confocal microscopy showing Flag-HPV-
16 E5 localisation within transiently transfected BeWo and JEG-3 cells. Data show 
one experiment representative of three independent experiments.
Fig. 2.  HPV-16 E5 on the opposite to HPV-16 E6/E7, alters viability of stably 
transfected cells (A) but the whole HPV-16 early region favour the viability of 
the cells (B). BeWo and C33a were stably transfected with the indicated constructs. 
At the end of the selection, LDH was measured in cells supernatants and the stable 
clones were colored by the crystal violet method. Each bar represents the mean ± SD 
of triplicates from a representative experiment. Statistical analysis on all experiments 
(n=5) showed only a statistically significant difference (P < 0.05) between pHPV-
16E5  transfected  cells  and  the  control  lacZ  transfected  cells  and  between  pHPV-
16Early transfected cells and their respective control, pLCR-GFP transfected cells.
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Fig.  3.  The AP-1 (A) and NF-κB (B) pathways are differentially  activated by 
HPV-16 E5 and E6/E7 oncoproteins. pAP-1-Luc or pNF-κB-Luc luciferase reporter 
plasmids were co-transfected in BeWo cells with pHPV-16 E5 or pHPV-16 E6/E7, 
and with pGL4-Luc-Renilla . Cell extracts were harvested 48 h later. For each extract, 
Firefly luciferase activity was normalized to the Renilla luciferase activity to correct 
for transfection efficiency. Each bar represents the mean ± SD of triplicates from a 
representative experiment. In all AP-1 (n=3) and all NF-kB trials (n=3), the difference 
between pHPV-16 E5 or pHPV-16 E6/E7 transfected cells versus pLacZ transfected 
cells was statistically significant (P < 0.05) as well between pHPV-16 E5 and pHPV-
16 E6/E7 transfected cells (P < 0.05).
Fig. 4.  HPV-16 E5 reduces adhesiveness of trophoblastic cells  to endometrial 
cells and to the plastic substrate.  BeWo cells were transiently cotransfected with 
pGL4-Luc-Renilla  plasmid  and  either  with  pEF6-Flag-HPV-16  E5 or  with  pEF6-
LacZ.  Forty  eight  hours  post-transfection,  transfected cells  were  added  to  90% 
confluent  RL-95  or  HEC-1A  endometrial  cells  and  further  incubated  for  2  h. 
Percentage  of  adhesiveness  was  calculated  by  normalizing  the  Renilla  Luciferase 
activity measured in the attached cells to the input. Each bar represents the mean ± 
SD  of  triplicates  from  a  representative  experiment  out  of  four  experiments.  A 
statistical significance (P < 0.05) was observed when analysis the data from the four 
combined experiments.
Fig. 5.  HPV-16 early proteins enhance migration and invasion of trophoblastic 
cells. BeWo cells were transiently transfected and 24 hr later suspended in 0.1% BSA 
supplemented DMEM and seeded in the upper compartment of a Boyden chamber, 
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with the lower compartment filled with 1 % BSA supplemented DMEM. For invasion 
assay,  the filter was coated with Matrigel (BD). Cell confluence was measured by 
crystal violet cells staining. The percentage of migration or invasion was calculated 
by  normalizing  absorbance  results  from  the  lower  surface  of  the  filter  to  the 
absorbance results from the control wells without filter. Each bar represents the mean 
±  SD  of  triplicates  from  a  representative  experiment.  Statistical  analysis  on  5 
independent trials showed significant results (P < 0.05).
Fig. 6.  HPV-16 E5, E6, E7, E6/E7 and E5/E6/E7 decrease E-cadherin expression 
in trophoblastic cells.  BeWo cells were transiently (right panel) or stably (left panel) 
transfected  with  the  indicated  plasmids.  E-cadherin  was  detected  in  total  protein 
extracts  by  western  blot.  β-Actin  served  as  loading  control.  Data  show  one 
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